Pursuant to regulation 29 and 33 of the Listing Regulations, Neogen Chemicals has informed that a meeting of the Board of Directors of the Company is schedule to be held on Saturday, May 13, 2023, to consider, approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2023 and to consider recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2023 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting. Further, as it has informed vide its letter dated March 31, 2023, the trading window closure period has commenced from April 1, 2023 and will end 48 hours after the declaration of Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2023 pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. This information is also being uploaded on the Company’s website at www.neogenchem.com
The above information is a part of company’s filings submitted to BSE.
